Katarzyna Kosicka

514 total citations
28 papers, 365 citations indexed

About

Katarzyna Kosicka is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Katarzyna Kosicka has authored 28 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Obstetrics and Gynecology. Recurrent topics in Katarzyna Kosicka's work include Hormonal Regulation and Hypertension (9 papers), Pregnancy and preeclampsia studies (8 papers) and Birth, Development, and Health (6 papers). Katarzyna Kosicka is often cited by papers focused on Hormonal Regulation and Hypertension (9 papers), Pregnancy and preeclampsia studies (8 papers) and Birth, Development, and Health (6 papers). Katarzyna Kosicka collaborates with scholars based in Poland, United States and Denmark. Katarzyna Kosicka's co-authors include Anna Siemiątkowska, Franciszek K. Główka, Marta Karaźniewicz‐Łada, Piotr J. Rudzki, Michał Kaza, Grzegorz H. Bręborowicz, Aleksandra Majchrzak‐Celińska, Leonid Kagan, Benjamin Kye Jyn Tan and Tanya M. Wildes and has published in prestigious journals such as PLoS ONE, Scientific Reports and Pain.

In The Last Decade

Katarzyna Kosicka

23 papers receiving 361 citations

Peers

Katarzyna Kosicka
Katarzyna Kosicka
Citations per year, relative to Katarzyna Kosicka Katarzyna Kosicka (= 1×) peers Anna Siemiątkowska

Countries citing papers authored by Katarzyna Kosicka

Since Specialization
Citations

This map shows the geographic impact of Katarzyna Kosicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Kosicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Kosicka more than expected).

Fields of papers citing papers by Katarzyna Kosicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Kosicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Kosicka. The network helps show where Katarzyna Kosicka may publish in the future.

Co-authorship network of co-authors of Katarzyna Kosicka

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Kosicka. A scholar is included among the top collaborators of Katarzyna Kosicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Kosicka. Katarzyna Kosicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kosicka, Katarzyna, et al.. (2025). Obesity-related drug-metabolizing enzyme expression alterations in the human liver. Biomedicine & Pharmacotherapy. 187. 118155–118155.
2.
Siemiątkowska, Anna, et al.. (2025). Bioanalytical considerations for quantification of ondansetron in rat microdialysis study using LC-MS/MS. Microchemical Journal. 211. 113082–113082.
3.
Romaniuk-Drapała, Aleksandra, et al.. (2025). Evaluation of reference genes for qPCR in human liver and kidney tissue from individuals with obesity. Scientific Reports. 15(1). 5347–5347. 3 indexed citations
5.
Abouzid, Mohamed, Katarzyna Kosicka, Marta Karaźniewicz‐Łada, et al.. (2024). Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine. Molecules. 29(2). 337–337. 2 indexed citations
6.
Kosicka, Katarzyna, et al.. (2024). Obesity-related drug transporter expression alterations in human liver and kidneys. Pharmacological Reports. 76(6). 1429–1442.
7.
Karaźniewicz‐Łada, Marta, et al.. (2023). New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 235. 115650–115650. 9 indexed citations
8.
Siemiątkowska, Anna, et al.. (2023). Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab. Cancer Immunology Immunotherapy. 72(6). 1853–1863. 2 indexed citations
9.
Kosicka, Katarzyna, et al.. (2019). Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring. Journal of Pharmaceutical and Biomedical Analysis. 178. 112952–112952. 17 indexed citations
10.
Kaza, Michał, Marta Karaźniewicz‐Łada, Katarzyna Kosicka, Anna Siemiątkowska, & Piotr J. Rudzki. (2018). Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?. Journal of Pharmaceutical and Biomedical Analysis. 165. 381–385. 117 indexed citations
11.
Kosicka, Katarzyna, et al.. (2018). Increased cortisol metabolism in women with pregnancy-related hypertension. Endocrine. 61(1). 125–133. 24 indexed citations
12.
Kosicka, Katarzyna, Przemysław Wirstlein, Anna Siemiątkowska, et al.. (2018). Maternal Serum Endocan Concentration in Pregnancies Complicated by Intrauterine Growth Restriction. Reproductive Sciences. 26(3). 370–376. 4 indexed citations
13.
Kosicka, Katarzyna, Przemysław Wirstlein, Anna Siemiątkowska, et al.. (2018). Serum endocan concentration and its correlation with severity of hypertensive disorders in pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine. 33(14). 2313–2319. 8 indexed citations
14.
Kosicka, Katarzyna, et al.. (2018). High-performance liquid chromatography methods for the analysis of endogenous cortisol and cortisone in human urine: comparison of mass spectrometry and fluorescence detection. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 56(1). 82–89. 10 indexed citations
15.
Majchrzak‐Celińska, Aleksandra, Katarzyna Kosicka, Franciszek K. Główka, et al.. (2017). HSD11B2, RUNX3, and LINE-1 Methylation in Placental DNA of Hypertensive Disorders of Pregnancy Patients. Reproductive Sciences. 24(11). 1520–1531. 17 indexed citations
16.
Kosicka, Katarzyna, et al.. (2015). Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone. PLoS ONE. 10(12). e0144343–e0144343. 26 indexed citations
17.
Kosicka, Katarzyna, et al.. (2014). Bupivacaine administered intrathecally versus rectally in the management of intractable rectal cancer pain in palliative care. OncoTargets and Therapy. 7. 1541–1541. 8 indexed citations
18.
Kotlińska–Lemieszek, Aleksandra, et al.. (2013). Lumbar paravertebral blockade as intractable pain management method in palliative care. OncoTargets and Therapy. 6. 1187–1187. 5 indexed citations
19.
Kosicka, Katarzyna, et al.. (2013). 11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis. Journal of Human Hypertension. 27(8). 510–515. 11 indexed citations
20.
Kosicka, Katarzyna, et al.. (2010). Glucocorticoids action in etiology of hypertension. Arterial Hypertension. 14(3). 208–215. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026